Navigation Links
U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
Date:3/14/2012

ter a 4 week or greater break.

Call your healthcare provider right away if you have:

  • Persistent leg pain; sudden shortness of breath; sudden blindness, partial or complete; severe pain in your chest; sudden, severe headache unlike your usual headaches; weakness or numbness in an arm or leg, or trouble speaking; yellowing of the skin or eyes

What are the most common side effects in Natazia clinical trials?

The most common side effects were headache/migraine, breast pain/discomfort/tenderness, menstrual disorders, nausea/vomiting, acne, mood changes, and weight gain.

Tell your healthcare provider about all medicines and herbal products you take including daily long-term treatment for chronic conditions such as seizures or cardiovascular disease.

Natazia does not protect against HIV infection (AIDS) or other STDs.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional information about Natazia, please see full prescribing information, including boxed warning, at www.natazia.com.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions.  As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare.  The company's aim is to discover and manufacture products that will improve human health worl
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Additional Manufacturer of Methoxsalen
2. FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen
3. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
4. FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
5. FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis
6. ASAM Approves Prescription Drug Policy
7. FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
8. FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
9. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
10. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
11. FDA Approves Hologics Cervista High Throughput Automation System for Cervical Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...
(Date:5/17/2013)... May 17, 2013 Oramed Pharmaceuticals ... oral drug delivery systems, announced today that the United ... Company,s Investigational New Drug application(IND) for ORMD-0801, its oral ... have the FDA clearance to proceed," stated ... trial is a major milestone for Oramed and we ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... 1, 2012 Anlit Advanced Nutrition Supplements ... dietary supplements for children, will present new and innovative products ... May 22-24, 2012 in Geneva, Switzerland. Anlit will ... Products Expo at Stand 3500. The company will present, ...
... SHENZHEN, China, April 30, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical ... developer, manufacturer and marketer of medical devices worldwide, announced ... Exchange Commission an Annual Report on Form 20-F that ... 31, 2011. An electronic version of Mindray,s Annual Report ...
Cached Medicine Technology:Anlit to Present New Dietary Supplements for Children at Vitafoods Europe 2012 2Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) ... edition of what is considered the "bible" of modern ... continues. "This is unprecedented, the amount of commentary ... of the American Psychiatric Association (APA). "It,s been an ... You have to evaluate it and then make your ...
(Date:5/18/2013)... (May 18, 2013) The use of a ... colonoscopy, according to new research presented today at ... begins days in advance of the procedure, includes ... to be taken at strict intervals. The better ... to see cancer and precancerous polyps in the ...
(Date:5/18/2013)... 2013 Assisted living and retirement ... safety and comfort of their residents. Systems Technologies ... with an effective and cost-efficient solution – VisionLink ... integrated, turnkey communications solution that helps nurses provide ... independence and privacy. , The VisionLink ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The Communities ... the special places we call home. These are the townships, ... They are the locations where the people are friendly and ... takes viewers off the highways and shares the best in ... both nations with an American sports and film celebrity. It ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss ... a result of stress, nutrient deficiency or wearing a ... of men suffer from male patterned baldness. ... hair transplant surgery, but additionally carries a hair care ... Bosley Professional Strength. Their product line is a five-step ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3
... VanTine HealthDay Reporter , FRIDAY, Dec. 3 (HealthDay News) ... interview, attractive women may be at a disadvantage, a new study ... men were twice as likely to generate requests for an interview, ... up to 30 percent less likely to get a response, whether ...
... FRIDAY, Dec. 3 (HealthDay News) -- If the expression "out ... may be at risk of forgetting about the global AIDS ... coverage of HIV/AIDS fell more than 70 percent in developed ... that tracked coverage in 115 leading broadsheet newspapers in 41 ...
... a quarter of Americans live in rural areas, which consistently ... suburban areas. Among the complex causes for this disparity is ... and almost 4 out of 10 rural residents live ... Finding the time, transportation, and financial resources for travel to ...
... News) -- Young women with a menopause-like condition called ... new study suggests. Women with the condition, called ... hormones, develop hot flashes, typically become infertile and, in ... develop as early as the teens or 20s, according ...
... children born with a rare genetic disease, according to ... Advancement of Science. The research was led by ... at Iowa State University, in collaboration with Dr. Patricia ... the Iowa State College of Veterinary Medicine, the University ...
... Goodwin HealthDay Reporter , THURSDAY, Dec. 2 (HealthDay ... circuitry of brain connections may someday be used to diagnose ... Boston and the University of Utah used MRIs to analyze ... in 30 males aged 8 to 26 with high-functioning autism ...
Cached Medicine News:Health News:Good Looks May Help Land the Interview -- for Men 2Health News:Good Looks May Help Land the Interview -- for Men 3Health News:Dramatic Decline Seen in AIDS News Coverage 2Health News:ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA 2Health News:Depression Screening Urged for Young Women With Menopause-Like Symptoms 2Health News:New discovery prevents symptoms of rare genetic disorder 2Health News:Brain Scan Might Someday Spot Autism 2Health News:Brain Scan Might Someday Spot Autism 3
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide....
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide....
... Instrument Set offers maximum distraction with minimal ... by the Tangent Posterior Impacted Instrument Set ... to reproduce the technique. Set offers 9 ... body distraction. A variety of sizes of ...
Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position....
Medicine Products: